SCHEMBL3853682

SCHEMBL3853682

Cc1n[nH]cc1-c1ccc2ncnc(N3CCc4ccccc4C3)c2c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 14/20 0.52
CYP3A4 P08684 13/20 0.52
ALDH1A1 P00352 12/20 0.52
LMNA P02545 12/20 0.52
CLK4 Q9HAZ1 10/20 0.52
TSHR P16473 9/20 0.52
HIF1A Q16665 9/20 0.52
MAPK1 P28482 8/20 0.52
MEN1 O00255 8/20 0.52
KMT2A Q03164 8/20 0.52
USP2 O75604 6/20 0.52
CYP2C19 P33261 11/20 0.51
KDM4E B2RXH2 8/20 0.49
CYP2D6 P10635 5/20 0.49
HPGD P15428 4/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
HSD17B10 Q99714 5/20 0.48
TP53 P04637 1/20 0.46
MAPT P10636 5/20 0.46
HTT P42858 4/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3846516 0.85 LMNA (0.50) CYP1A2CYP3A4ALDH1A1LMNACLK4
SCHEMBL3877387 0.83 CYP1A2 (0.52) CYP1A2CYP3A4ALDH1A1LMNACLK4
SCHEMBL3851339 0.83 CYP3A4 (0.67) CYP1A2CYP3A4ALDH1A1LMNACLK4
SCHEMBL3856130 0.81 AKT1 (0.50) CYP1A2CYP3A4ALDH1A1LMNACLK4
SCHEMBL3847066 0.80 CYP1A2 (0.61) CYP1A2CYP3A4ALDH1A1LMNACLK4
SCHEMBL30734213 0.80 ACHE (0.57) CYP1A2CYP3A4ALDH1A1LMNACLK4
SCHEMBL10072172 0.79 KDM4E (0.64) CYP1A2CYP3A4ALDH1A1LMNACLK4
SCHEMBL3847901 0.79 CYP1A2 (0.53) CYP1A2CYP3A4ALDH1A1LMNACLK4
SCHEMBL3847428 0.78 ACHE (0.58) CYP1A2CYP3A4ALDH1A1LMNACLK4
SCHEMBL3846258 0.78 CYP1A2 (0.52) CYP1A2CYP3A4ALDH1A1LMNACLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed